In a new study researchers have claimed an experimental vaccine has been 100 percent effective against Ebola virus. It is hoped the so-called rVSV-ZEBOV will provide better protection to people.
Details of the study were published on Thursday in The Lancet.
Ebola was first discovered in 1976 and in 2014 an outbreak of it ravaged West Africa killing more than 11,000 people.
Last year the experimental vaccine studied for few months in a trial led by World Health Organization (WHO) in conjunction with Guinea’s Ministry of Health.
More than 11,000 people were involved in the trial and about half of them were given the experimental vaccine and others were denied of it. It was found those who were given the rVSV-ZEBOV were not infected of the virus even after 10 or longer days while 23 cases were recorded among the other group.
However, those who have been given the vaccine reported fatigue, headaches and muscle pain. Also, two of them had serious reactions including one allergic one.
The Ebola virus is highly contagious and the families who care for sick loves ones risk themselves getting infected.
John-Arne Rottingen of the Norwegian Institute of Public Health said, “The premise is that by vaccinating all people who have come into contact with an infected person, you create a protective ‘ring’ and stop the virus from spreading further.”